MaximYankelevichMD

PubMed

• Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
  Archana Thakur, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Qin Liu, Maxim Yankelevich, Shakeel Modak, Daniel W L...> ;Journal for Immunotherapy of Cancer. 2024 Mar 21
• Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
  Archana Thakur, Roland Chu, Jeffrey Taub, Alissa Martin, Dana L Schalk, Amy Schienshang, Sara Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony Shields, Lawrence G L...> ;Research Square. 2023 Nov 9
• 40 citations
  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
  Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U K...> ;Nature Medicine. 2023 Jun 1
• Patterns and correlates of preserved humoral immunity to vaccines in children following allogeneic hematopoietic stem cell transplantation
  Eman Al-Antary, Meret Henry, Jessica L. Spruit, Maxim Yankelevich, Roland Chu, Yaddanapudi Ravindranath, Süreyya Savaşan> ;Pediatric Transplantation. 2021 Aug 1
• Ongoing response in a multiply relapsed metastatic posterior fossa ependymoma a after vorinostat and concomitant irradiation
  Hamza S. Gorsi, Stephanie A. Toll, Sandeep Sood, Steven Miler, Deniz Altinok, Chandan Kumar-Sinha, Rajen Mody, Maxim Yankelevich> ;Journal of Pediatric Hematology/oncology. 2021 Apr 28
• 4 citations
  Molecular insights into malignant progression of atypical choroid plexus papilloma
  Maxim Yankelevich, Jonathan L. Finlay, Hamza S. Gorsi, William J. Kupsky, Daniel R. Boue, Carl Koschmann, Chandan Kumar-Sinha, Rajen Mody> ;Cold Spring Harbor Molecular Case Studies. 2021 Feb 19
• 1 citations
  Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized...
  Maxim Yankelevich, David J. Hoogstra, Judith Abrams, Roland Chu, Kanta Bhambhani, Jeffrey W. Taub> ;Pediatric Hematology and Oncology. 2020 Jul 9
• Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib.
  Hamza Gorsi, Neena Marupudi, Sandeep Sood, Deniz Altinok, Maxim Yankelevich> ;Pediatric Neurosurgery. 2020 Jan 1
• 1 citations
  Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children.
  Patricia Rayner, Jessica L. Spruit, Roland Chu, Maxim Yankelevich, Meret Henry, Yaddanapudi Ravindranath, Süreyya Savaşan> ;Journal of Pediatric Hematology/oncology. 2019 Aug 1
• Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy.
  Maxim Yankelevich, Süreyya Savaşan, Igor Dolgopolov, Roland Chu, George Mentkevich> ;Case Reports in Oncological Medicine. 2017 Nov 12
• 33 citations
  Choroid plexus carcinoma in children: the Head Start experience.
  Wafik Zaky, Girish Dhall, Soumen Khatua, Robert J. Brown, Kevin Ginn, Sharon Gardner, Vedat O. Yildiz, Maxim Yankelevich, Jonathan L. Finlay> ;Pediatric Blood & Cancer. 2015 May 1
• 6 citations
  Hematopoietic Cell Transplantation and Cellular Therapeutics in the Treatment of Childhood Malignancies
  Kanwaldeep Mallhi, Lawrence G. Lum, Kirk R. Schultz, Maxim Yankelevich> ;Pediatric Clinics of North America. 2015 Feb 1
• 11 citations
  Predictive Factors for Blood Stream Infections in Children with Cancer
  Dimitrios Doganis, Basim I. Asmar, Maxim Yankelevich, Ronald Thomas, Yaddanapudi Ravindranath> ;Pediatric Hematology and Oncology. 2013 Jul 12
• 8 citations
  How Many Sources Should Be Cultured for the Diagnosis of a Blood Stream Infection in Children with Cancer
  Dimitrios Doganis, Basim I. Asmar, Maxim Yankelevich, Ronald Thomas, Yaddanapudi Ravindranath> ;Pediatric Hematology and Oncology. 2013 Jul 12
• 59 citations
  Anti-CD3 × Anti-GD2 Bispecific Antibody Redirects T-Cell Cytolytic Activity to Neuroblastoma Targets
  Maxim Yankelevich, Sri Vidya Kondadasula, Archana Thakur, Steven Buck, Nai-Kong V. Cheung, Lawrence G. Lum> ;Pediatric Blood & Cancer. 2012 Dec 15
• 15 citations
  Efficacy of delayed administration of post-chemotherapy granulocyte colony-stimulating factor: evidence from murine studies of bone marrow cell kinetics
  Maxim Yankelevich, Margaret A. Goodell, Joseph Kaplan> ;Experimental Hematology. 2008 Jan 1
• 5 citations
  Delayed introduction of G-CSF after chemotherapy does not affect peripheral blood stem cell yield and engraftment kinetics in children with high-risk malignancies: ret...
  Igor Dolgopolov, Ludmila Andreeva, Maxim Yankelevich, Demur Mscheidze, Stuart E. Siegel, George Mentkevich> ;American Journal of Hematology. 2003 Aug 1
• Feasibility and safety of peripheral blood stem cell collection in children with poor-prognosis solid tumors: a single center experience.
  Dolgopolov, I., Yankelevich, M., Andreeva, L., Mscheidze, D., Ijoguine, D., Siegel, S., Mentkevich, G.> ;Pediatr Hematol Oncol. 1999 Jul 17
• Join now to see all

Lectures

• Phase I study of OKT3 x hu3F8 bispecific antibody (GD2Bi) armed T cells (GD2BATs) in GD2-positive tumors. 
  2019 ASCO Annual Meeting - 6/1/2019